bf/NASDAQ:FHTX_icon.jpeg

COM:FOGHORNTX

Foghorn Therapeutics Inc.

  • Stock

Last Close

7.86

21/11 20:40

Market Cap

265.58M

Beta: -

Volume Today

43.50K

Avg: -

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of ...Show More

peer of

investor of

competitor of